Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Novartis AG Unloads Former New York Space for $18 Million, Resold for $30 Million September 14, 2017 Where High-Flying Cara Therapeutics Could be in 5 Years October 5, 2017 The Medicines Company Slashes Hundreds of Jobs in Restructuring October 24, 2017
